James V Caruso is President and CEO of Cellectar Biosciences, Inc.. Currently has a direct ownership of 49,236 shares of CLRB, which is worth approximately $11,816. The most recent transaction as insider was on Dec 08, 2023, when has been sold 40,596 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49.2K
0% 3M change
0% 12M change
Total Value Held $11,816

JAMES V CARUSO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 08 2023
BUY
Grant, award, or other acquisition
-
40,596 Added 45.19%
49,236 Common Stock
Mar 04 2021
BUY
Open market or private purchase
$8,670 $1.7 p/Share
5,100 Added 5.57%
86,401 Common Stock
Dec 28 2020
BUY
Open market or private purchase
$50,000 $1.35 p/Share
37,037 Added 31.3%
81,301 Common Stock
JVC

James V Caruso

President and CEO
Florham, NJ

Track Institutional and Insider Activities on CLRB

Follow Cellectar Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLRB shares.

Notify only if

Insider Trading

Get notified when an Cellectar Biosciences, Inc. insider buys or sells CLRB shares.

Notify only if

News

Receive news related to Cellectar Biosciences, Inc.

Track Activities on CLRB